CWM LLC lifted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 124.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 95,087 shares of the medical instruments supplier's stock after acquiring an additional 52,727 shares during the quarter. CWM LLC's holdings in DENTSPLY SIRONA were worth $1,421,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. acquired a new position in DENTSPLY SIRONA during the 1st quarter worth $25,000. Colonial Trust Co SC acquired a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at about $26,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after buying an additional 1,568 shares during the last quarter. True Wealth Design LLC raised its position in shares of DENTSPLY SIRONA by 866.7% during the fourth quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock valued at $41,000 after buying an additional 1,950 shares during the last quarter. Finally, Allworth Financial LP raised its position in shares of DENTSPLY SIRONA by 175.8% during the first quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier's stock valued at $54,000 after buying an additional 2,517 shares during the last quarter. 95.70% of the stock is owned by institutional investors.
Analysts Set New Price Targets
XRAY has been the topic of a number of research analyst reports. Piper Sandler dropped their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. UBS Group decreased their target price on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Barrington Research reaffirmed an "outperform" rating and issued a $21.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research report on Tuesday, April 15th. Finally, Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research report on Monday. Ten research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $19.60.
Get Our Latest Stock Report on DENTSPLY SIRONA
DENTSPLY SIRONA Stock Performance
XRAY traded up $0.78 during trading on Tuesday, hitting $16.41. 5,992,782 shares of the stock were exchanged, compared to its average volume of 2,927,056. The firm has a market capitalization of $3.27 billion, a P/E ratio of -3.61, a PEG ratio of 1.12 and a beta of 0.94. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 0.79. The stock has a fifty day moving average price of $16.07 and a two-hundred day moving average price of $16.26. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $27.95.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. The business had revenue of $879.00 million for the quarter, compared to the consensus estimate of $854.75 million. During the same quarter in the previous year, the company posted $0.42 earnings per share. DENTSPLY SIRONA's revenue for the quarter was down 7.8% compared to the same quarter last year. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.
DENTSPLY SIRONA Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, July 11th. Stockholders of record on Friday, June 27th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, June 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.90%. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.